Report Overview
This report provides a deep insight into the global Gene Therapy for Neurodegenerative Diseases market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Therapy for Neurodegenerative Diseases Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Therapy for Neurodegenerative Diseases market in any manner.
Global Gene Therapy for Neurodegenerative Diseases Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Voyager Therapeutics
Uniqure N.V.
Axovant Gene Therapies
Novartis Ag
Amicus Therapeutics
Regenxbio Inc.
Sarepta Therapeutics
Gensight Biologics
Krystal Biotech
Avexis
Market Segmentation (by Type)
Gene Replacement Therapy
Gene Silencing Therapy
Gene Editing Therapy
Enzyme Replacement Therapy
Market Segmentation (by Application)
Hospitals and Clinics
Research Institutions
Biotechnology Companies
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Gene Therapy for Neurodegenerative Diseases Market
? Overview of the regional outlook of the Gene Therapy for Neurodegenerative Diseases Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy for Neurodegenerative Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy for Neurodegenerative Diseases
1.2 Key Market Segments
1.2.1 Gene Therapy for Neurodegenerative Diseases Segment by Type
1.2.2 Gene Therapy for Neurodegenerative Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy for Neurodegenerative Diseases Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy for Neurodegenerative Diseases Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy for Neurodegenerative Diseases Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy for Neurodegenerative Diseases Market Competitive Landscape
3.1 Global Gene Therapy for Neurodegenerative Diseases Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy for Neurodegenerative Diseases Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy for Neurodegenerative Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy for Neurodegenerative Diseases Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy for Neurodegenerative Diseases Sales Sites, Area Served, Product Type
3.6 Gene Therapy for Neurodegenerative Diseases Market Competitive Situation and Trends
3.6.1 Gene Therapy for Neurodegenerative Diseases Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy for Neurodegenerative Diseases Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy for Neurodegenerative Diseases Industry Chain Analysis
4.1 Gene Therapy for Neurodegenerative Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy for Neurodegenerative Diseases Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy for Neurodegenerative Diseases Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy for Neurodegenerative Diseases Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy for Neurodegenerative Diseases Price by Type (2019-2024)
7 Gene Therapy for Neurodegenerative Diseases Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy for Neurodegenerative Diseases Market Sales by Application (2019-2024)
7.3 Global Gene Therapy for Neurodegenerative Diseases Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy for Neurodegenerative Diseases Sales Growth Rate by Application (2019-2024)
8 Gene Therapy for Neurodegenerative Diseases Market Segmentation by Region
8.1 Global Gene Therapy for Neurodegenerative Diseases Sales by Region
8.1.1 Global Gene Therapy for Neurodegenerative Diseases Sales by Region
8.1.2 Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy for Neurodegenerative Diseases Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy for Neurodegenerative Diseases Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy for Neurodegenerative Diseases Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy for Neurodegenerative Diseases Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy for Neurodegenerative Diseases Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Voyager Therapeutics
9.1.1 Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Basic Information
9.1.2 Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Product Overview
9.1.3 Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.1.4 Voyager Therapeutics Business Overview
9.1.5 Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases SWOT Analysis
9.1.6 Voyager Therapeutics Recent Developments
9.2 Uniqure N.V.
9.2.1 Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Basic Information
9.2.2 Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Product Overview
9.2.3 Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.2.4 Uniqure N.V. Business Overview
9.2.5 Uniqure N.V. Gene Therapy for Neurodegenerative Diseases SWOT Analysis
9.2.6 Uniqure N.V. Recent Developments
9.3 Axovant Gene Therapies
9.3.1 Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Basic Information
9.3.2 Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Product Overview
9.3.3 Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.3.4 Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases SWOT Analysis
9.3.5 Axovant Gene Therapies Business Overview
9.3.6 Axovant Gene Therapies Recent Developments
9.4 Novartis Ag
9.4.1 Novartis Ag Gene Therapy for Neurodegenerative Diseases Basic Information
9.4.2 Novartis Ag Gene Therapy for Neurodegenerative Diseases Product Overview
9.4.3 Novartis Ag Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.4.4 Novartis Ag Business Overview
9.4.5 Novartis Ag Recent Developments
9.5 Amicus Therapeutics
9.5.1 Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Basic Information
9.5.2 Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Product Overview
9.5.3 Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.5.4 Amicus Therapeutics Business Overview
9.5.5 Amicus Therapeutics Recent Developments
9.6 Regenxbio Inc.
9.6.1 Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Basic Information
9.6.2 Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Product Overview
9.6.3 Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.6.4 Regenxbio Inc. Business Overview
9.6.5 Regenxbio Inc. Recent Developments
9.7 Sarepta Therapeutics
9.7.1 Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Basic Information
9.7.2 Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Product Overview
9.7.3 Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.7.4 Sarepta Therapeutics Business Overview
9.7.5 Sarepta Therapeutics Recent Developments
9.8 Gensight Biologics
9.8.1 Gensight Biologics Gene Therapy for Neurodegenerative Diseases Basic Information
9.8.2 Gensight Biologics Gene Therapy for Neurodegenerative Diseases Product Overview
9.8.3 Gensight Biologics Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.8.4 Gensight Biologics Business Overview
9.8.5 Gensight Biologics Recent Developments
9.9 Krystal Biotech
9.9.1 Krystal Biotech Gene Therapy for Neurodegenerative Diseases Basic Information
9.9.2 Krystal Biotech Gene Therapy for Neurodegenerative Diseases Product Overview
9.9.3 Krystal Biotech Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.9.4 Krystal Biotech Business Overview
9.9.5 Krystal Biotech Recent Developments
9.10 Avexis
9.10.1 Avexis Gene Therapy for Neurodegenerative Diseases Basic Information
9.10.2 Avexis Gene Therapy for Neurodegenerative Diseases Product Overview
9.10.3 Avexis Gene Therapy for Neurodegenerative Diseases Product Market Performance
9.10.4 Avexis Business Overview
9.10.5 Avexis Recent Developments
10 Gene Therapy for Neurodegenerative Diseases Market Forecast by Region
10.1 Global Gene Therapy for Neurodegenerative Diseases Market Size Forecast
10.2 Global Gene Therapy for Neurodegenerative Diseases Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Region
10.2.4 South America Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy for Neurodegenerative Diseases by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene Therapy for Neurodegenerative Diseases Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy for Neurodegenerative Diseases by Type (2025-2030)
11.1.2 Global Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy for Neurodegenerative Diseases by Type (2025-2030)
11.2 Global Gene Therapy for Neurodegenerative Diseases Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy for Neurodegenerative Diseases Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy for Neurodegenerative Diseases Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene Therapy for Neurodegenerative Diseases Market Size Comparison by Region (M USD)
Table 5. Global Gene Therapy for Neurodegenerative Diseases Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene Therapy for Neurodegenerative Diseases Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene Therapy for Neurodegenerative Diseases Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Neurodegenerative Diseases as of 2022)
Table 10. Global Market Gene Therapy for Neurodegenerative Diseases Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene Therapy for Neurodegenerative Diseases Sales Sites and Area Served
Table 12. Manufacturers Gene Therapy for Neurodegenerative Diseases Product Type
Table 13. Global Gene Therapy for Neurodegenerative Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene Therapy for Neurodegenerative Diseases
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene Therapy for Neurodegenerative Diseases Market Challenges
Table 22. Global Gene Therapy for Neurodegenerative Diseases Sales by Type (K Units)
Table 23. Global Gene Therapy for Neurodegenerative Diseases Market Size by Type (M USD)
Table 24. Global Gene Therapy for Neurodegenerative Diseases Sales (K Units) by Type (2019-2024)
Table 25. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Type (2019-2024)
Table 26. Global Gene Therapy for Neurodegenerative Diseases Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene Therapy for Neurodegenerative Diseases Market Size Share by Type (2019-2024)
Table 28. Global Gene Therapy for Neurodegenerative Diseases Price (USD/Unit) by Type (2019-2024)
Table 29. Global Gene Therapy for Neurodegenerative Diseases Sales (K Units) by Application
Table 30. Global Gene Therapy for Neurodegenerative Diseases Market Size by Application
Table 31. Global Gene Therapy for Neurodegenerative Diseases Sales by Application (2019-2024) & (K Units)
Table 32. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Application (2019-2024)
Table 33. Global Gene Therapy for Neurodegenerative Diseases Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene Therapy for Neurodegenerative Diseases Market Share by Application (2019-2024)
Table 35. Global Gene Therapy for Neurodegenerative Diseases Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene Therapy for Neurodegenerative Diseases Sales by Region (2019-2024) & (K Units)
Table 37. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Region (2019-2024)
Table 38. North America Gene Therapy for Neurodegenerative Diseases Sales by Country (2019-2024) & (K Units)
Table 39. Europe Gene Therapy for Neurodegenerative Diseases Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Gene Therapy for Neurodegenerative Diseases Sales by Region (2019-2024) & (K Units)
Table 41. South America Gene Therapy for Neurodegenerative Diseases Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Gene Therapy for Neurodegenerative Diseases Sales by Region (2019-2024) & (K Units)
Table 43. Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Basic Information
Table 44. Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Product Overview
Table 45. Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Voyager Therapeutics Business Overview
Table 47. Voyager Therapeutics Gene Therapy for Neurodegenerative Diseases SWOT Analysis
Table 48. Voyager Therapeutics Recent Developments
Table 49. Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Basic Information
Table 50. Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Product Overview
Table 51. Uniqure N.V. Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Uniqure N.V. Business Overview
Table 53. Uniqure N.V. Gene Therapy for Neurodegenerative Diseases SWOT Analysis
Table 54. Uniqure N.V. Recent Developments
Table 55. Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Basic Information
Table 56. Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Product Overview
Table 57. Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Axovant Gene Therapies Gene Therapy for Neurodegenerative Diseases SWOT Analysis
Table 59. Axovant Gene Therapies Business Overview
Table 60. Axovant Gene Therapies Recent Developments
Table 61. Novartis Ag Gene Therapy for Neurodegenerative Diseases Basic Information
Table 62. Novartis Ag Gene Therapy for Neurodegenerative Diseases Product Overview
Table 63. Novartis Ag Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Novartis Ag Business Overview
Table 65. Novartis Ag Recent Developments
Table 66. Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Basic Information
Table 67. Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Product Overview
Table 68. Amicus Therapeutics Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Amicus Therapeutics Business Overview
Table 70. Amicus Therapeutics Recent Developments
Table 71. Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Basic Information
Table 72. Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Product Overview
Table 73. Regenxbio Inc. Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Regenxbio Inc. Business Overview
Table 75. Regenxbio Inc. Recent Developments
Table 76. Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Basic Information
Table 77. Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Product Overview
Table 78. Sarepta Therapeutics Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Sarepta Therapeutics Business Overview
Table 80. Sarepta Therapeutics Recent Developments
Table 81. Gensight Biologics Gene Therapy for Neurodegenerative Diseases Basic Information
Table 82. Gensight Biologics Gene Therapy for Neurodegenerative Diseases Product Overview
Table 83. Gensight Biologics Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Gensight Biologics Business Overview
Table 85. Gensight Biologics Recent Developments
Table 86. Krystal Biotech Gene Therapy for Neurodegenerative Diseases Basic Information
Table 87. Krystal Biotech Gene Therapy for Neurodegenerative Diseases Product Overview
Table 88. Krystal Biotech Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Krystal Biotech Business Overview
Table 90. Krystal Biotech Recent Developments
Table 91. Avexis Gene Therapy for Neurodegenerative Diseases Basic Information
Table 92. Avexis Gene Therapy for Neurodegenerative Diseases Product Overview
Table 93. Avexis Gene Therapy for Neurodegenerative Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Avexis Business Overview
Table 95. Avexis Recent Developments
Table 96. Global Gene Therapy for Neurodegenerative Diseases Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Gene Therapy for Neurodegenerative Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Gene Therapy for Neurodegenerative Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Gene Therapy for Neurodegenerative Diseases Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Gene Therapy for Neurodegenerative Diseases Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Gene Therapy for Neurodegenerative Diseases Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Gene Therapy for Neurodegenerative Diseases Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Gene Therapy for Neurodegenerative Diseases Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Gene Therapy for Neurodegenerative Diseases Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Gene Therapy for Neurodegenerative Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene Therapy for Neurodegenerative Diseases Market Size (M USD), 2019-2030
Figure 5. Global Gene Therapy for Neurodegenerative Diseases Market Size (M USD) (2019-2030)
Figure 6. Global Gene Therapy for Neurodegenerative Diseases Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene Therapy for Neurodegenerative Diseases Market Size by Country (M USD)
Figure 11. Gene Therapy for Neurodegenerative Diseases Sales Share by Manufacturers in 2023
Figure 12. Global Gene Therapy for Neurodegenerative Diseases Revenue Share by Manufacturers in 2023
Figure 13. Gene Therapy for Neurodegenerative Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene Therapy for Neurodegenerative Diseases Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene Therapy for Neurodegenerative Diseases Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene Therapy for Neurodegenerative Diseases Market Share by Type
Figure 18. Sales Market Share of Gene Therapy for Neurodegenerative Diseases by Type (2019-2024)
Figure 19. Sales Market Share of Gene Therapy for Neurodegenerative Diseases by Type in 2023
Figure 20. Market Size Share of Gene Therapy for Neurodegenerative Diseases by Type (2019-2024)
Figure 21. Market Size Market Share of Gene Therapy for Neurodegenerative Diseases by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene Therapy for Neurodegenerative Diseases Market Share by Application
Figure 24. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Application (2019-2024)
Figure 25. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Application in 2023
Figure 26. Global Gene Therapy for Neurodegenerative Diseases Market Share by Application (2019-2024)
Figure 27. Global Gene Therapy for Neurodegenerative Diseases Market Share by Application in 2023
Figure 28. Global Gene Therapy for Neurodegenerative Diseases Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share by Region (2019-2024)
Figure 30. North America Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Gene Therapy for Neurodegenerative Diseases Sales Market Share by Country in 2023
Figure 32. U.S. Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Gene Therapy for Neurodegenerative Diseases Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Gene Therapy for Neurodegenerative Diseases Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Gene Therapy for Neurodegenerative Diseases Sales Market Share by Country in 2023
Figure 37. Germany Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Gene Therapy for Neurodegenerative Diseases Sales Market Share by Region in 2023
Figure 44. China Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 50. South America Gene Therapy for Neurodegenerative Diseases Sales Market Share by Country in 2023
Figure 51. Brazil Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Gene Therapy for Neurodegenerative Diseases Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Gene Therapy for Neurodegenerative Diseases Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Gene Therapy for Neurodegenerative Diseases Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Gene Therapy for Neurodegenerative Diseases Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene Therapy for Neurodegenerative Diseases Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene Therapy for Neurodegenerative Diseases Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene Therapy for Neurodegenerative Diseases Sales Forecast by Application (2025-2030)
Figure 66. Global Gene Therapy for Neurodegenerative Diseases Market Share Forecast by Application (2025-2030)
